421 studies found for:    bisphosphonates
Show Display Options
Rank Status Study
1 Recruiting Bisphosphonates Effects On Alveolar Bone Among Osteoporotic Women
Condition: Osteoporosis
Intervention: Drug: Bisphosphonates
2 Active, not recruiting Denosumab in Current Users of Bisphosphonates for Glucocorticoid-induced Osteoporosis
Condition: Osteoporosis
Interventions: Drug: Denosumab;   Drug: bisphosphonates
3 Recruiting Bisphosphonate Biomarker Study
Conditions: Osteoporosis, With or Without Treatment;   Bisphosphonate Treatment;   Atypical Femur Fracture;   Bisphosphonate Related Osteonecrosis of the Jaws (BRONJ);   Healthy Volunteers
4 Completed Effects of Bisphosphonates and Nutritional Supplementation After a Hip Fracture
Condition: Hip Fracture
Interventions: Drug: Risedronate;   Other: Nutritional supplement;   Dietary Supplement: Calcium and vitamin D3
5 Completed
Has Results
Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) Bisphosphonates
Conditions: Bone Metastases in Men With Hormone-Refractory Prostate Cancer;   Bone Metastases in Subjects With Advanced Breast Cancer;   Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma
Interventions: Genetic: AMG 162 180 mg (SC) q 12 weeks;   Drug: IV Bisphosphonate q 4 weeks;   Genetic: AMG 162- 180 mg q 4 weeks
6 Recruiting Assessment of Platelet Rich Fibrin Efficiency on Healing Delay and on Jawbone Osteochemonecrosis Provoked by Bisphosphonates
Condition: Jawbone Osteochemonecrosis Induced by Bisphosphonates
Interventions: Procedure: Bone curettage + PRF;   Procedure: Bone curettage alone
7 Enrolling by invitation Evaluation of the Risk for Radiographic and Clinical Nonunion in Patients With Previous Bisphosphonates Therapy.
Condition: Non-union or Delayed Healing Fractures
8 Recruiting Radiographic Influences of Bisphosphonate Treatment on Femur
Condition: Femur Fracture
9 Completed Assessment of Response to Treatment of Osteoporosis With Oral Bisphosphonates in Patients With Muscular Dystrophy
Conditions: Osteoporosis;   Muscular Dystrophy;   Cystic Fibrosis
Intervention: Drug: Bisphosphonate treatment
10 Terminated Use of Oral Bisphosphonates in the Treatment of Osteoporosis of Non-walking Children With Cerebral Palsy
Conditions: Osteoporosis;   Cerebral Palsy
Interventions: Drug: FOSAMAX;   Other: PLACEBO
11 Unknown  Pharmacokinetic, Safety and Tolerability Study of SC Administered Bisphosphonate With rHuPH20 vs Bisphosphonate Alone
Condition: Risk Factors for or a Diagnosis of Osteoporosis
Intervention: Drug: rHuPH20
12 Completed Awareness to Osteopenia's Treatment by Bisphosphonate in Male Suffering From Prostate Cancer
Conditions: Osteoporosis;   Prostate Cancer
13 Completed
Has Results
Denosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast Cancer
Conditions: Breast Cancer;   Metastases;   Bone Metastases in Subjects With Advanced Breast Cancer
Interventions: Biological: Denosumab;   Drug: IV Bisphosphonates
14 Completed Quality of Life(QoL) in Korean Postmenopausal Osteoporosis Patients With Bisphosphonate Treatment
Condition: Osteoporosis, Postmenopausal
Intervention: Other: OPSAT-Q
15 Completed The Influence of Bisphosphonates in the Oral Cavity in Children
Conditions: Oral Cavity;   Osteomyelitis;   Necrosis of the Jaws
16 Completed Proposal For The Development Of A Well Defined Database For Patients With Oral Bisphosphonate-Related Osteonecrosis
Condition: Osteonecrosis
Intervention: Other: Observational
17 Completed Bisphosphonate-Associated Jaw Osteonecrosis and PET Imaging
Conditions: Bisphosphonate-associated ONJ;   Osteomyelitis of the Jaw;   Osteolytic Lesions of the Jaw;   Osteoradionecrosis of the Jaw
18 Active, not recruiting Queen's University Investigation of Calcification in Chronic Kidney Disease
Condition: Chronic Kidney Disease
Interventions: Drug: Bisphosphonate;   Drug: Placebo
19 Recruiting Short-term Functional Recovery Between Early- and Late Bisphosphonate Treatment Following Hemiarthroplasty
Conditions: Osteoporotic Fractures;   Femoral Neck Fracture
Intervention: Drug: Risedronate
20 Completed Randomized Controlled Trial of Hyperbaric Oxygen in Patients Who Have Taken Bisphosphonates
Condition: Osteonecrosis
Interventions: Device: hyperbaric oxygen;   Device: non-treated control group

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years